homocysteine and Hyperandrogenism

homocysteine has been researched along with Hyperandrogenism in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Dong, G; Kang, Y; Kong, N; Li, T; Liu, Y; Sheng, X; Sun, H; Wang, Z; Zhang, M1
Emre, O; Leyla, M; Muammer, D; Nafiye, Y; Senol, K; Sevtap, K1
Grodnitskaya, EE; Kurtser, MA1
De Leo, V; La Marca, A; Morgante, G; Petraglia, F; Setacci, C; Setacci, F1

Trials

1 trial(s) available for homocysteine and Hyperandrogenism

ArticleYear
The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome.
    Fertility and sterility, 2010, Volume: 93, Issue:6

    Topics: Adult; Biomarkers; Body Mass Index; Cross-Sectional Studies; Female; Fertilization in Vitro; Homocysteine; Humans; Hyperandrogenism; Ideal Body Weight; Infertility; Insulin Resistance; Male; Obesity; Ovarian Follicle; Polycystic Ovary Syndrome; Pregnancy; Prognosis; Treatment Outcome; Young Adult

2010

Other Studies

3 other study(ies) available for homocysteine and Hyperandrogenism

ArticleYear
Increased homocysteine regulated by androgen activates autophagy by suppressing the mammalian target of rapamycin pathway in the granulosa cells of polycystic ovary syndrome mice.
    Bioengineered, 2022, Volume: 13, Issue:4

    Topics: Androgens; Animals; Autophagy; Female; Granulosa Cells; Homocysteine; Humans; Hyperandrogenism; Male; Mammals; Mice; Mice, Inbred ICR; Polycystic Ovary Syndrome; Sirolimus; TOR Serine-Threonine Kinases

2022
Homocysteine metabolism in polycystic ovary syndrome.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2012, Volume: 28, Issue:3

    Topics: Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperandrogenism; Hyperhomocysteinemia; Insulin Resistance; Polycystic Ovary Syndrome; Risk Factors

2012
The cardiovascular risk factor homocysteine is not elevated in young women with hyperandrogenism or hypoestrogenism.
    Gynecologic and obstetric investigation, 2002, Volume: 53, Issue:4

    Topics: Adult; Amenorrhea; Biomarkers; Blood Chemical Analysis; Cardiovascular Diseases; Case-Control Studies; Estrogens; Female; Follicle Stimulating Hormone; Homocysteine; Humans; Hyperandrogenism; Luteinizing Hormone; Probability; Prognosis; Reference Values; Sensitivity and Specificity; Testosterone

2002